FDA Investigator Debra J Bennett

Debra J Bennett has inspections in 6 countries as of 07 Sep 2023. Debra J Bennett has collaborated with a combinined 3939 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
69
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, France, Germany, Argentina
Co-Investigator(s):
Alan D Centi, Alicia M Mozzachio, Alla Kachko, PhD, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Karnick, Ann Marie Montemurro, Ann Marie Schofield, Anthony A Charity, Ariel Cruz Figueroa, Audrey Thereset Uy, Azza Talaat, Beichner, Benton M Ketron, Brandi L Garbutt, Brentley S Collins, Brett R Havranek, Brian D Young, Brian S Keefer, Calvin W Edwards, Cara M Minelli, Cary Greene, CDR Jeremy L Wally, PhD, Chamberlain, Chao Ming Tsai, Charles M Edwards, Christian D Lynch (CDL), Christina J Sauder, PhD, Christina K Theodorou, Christopher J Adams, Colleen M Damon, Craig D Zagata, Crystal A Harlan, Cynthia Jim, CSO, Daniel W Johnson, Dave Hafner, David A Schwartz, David J Hafner, David L Pearce, Deborah G Haney Cozzone, Deborah J Parris, Debra L Pagano, Denise M Digiulio, Dennis Cantellops Paite, Derek S Dealy, Diane Kelley, Douglas C Kovacs, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Eileen A Liu, Elaine E Gilfillan, Ellen Huang, Emest F Bizjak, Eric S Myskowski, Erika V Butler, Frank W Perrella, Gayle S Lawson, Gene D Arcy, George Pyramides, Gess, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Harperd, Haruhiko Murata, Helen B Ricalde, Ivis Lnegron Torres, J David Doleski, Jacqueline Mdiaz Albertini, Jaison J Eapen, James C Illuminati, James M Mason, James P Mcevoy, Javier O Vega, Jean Blackston Hill, Jean Blackstone Hill, Jeannie R Mayberry, Jeen S Min, Joan A Loreng, Joan Adamo, Joanne Heim, Joanne M Hajoway, Joey V Quitania, Jose E Melendez, DDC, Joseph Brady, Joseph George, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Joshua C Schafer, Juanita P Versace, Judith A Paterson, Julianne C Mccullough, Jullianne C Mccullough, Junho Pak, Junho Park, Karyn M Campbell, Kathleen B Mihalik, Kathryn Carbone, MD, Kelly N Kerr, Kendra L Brooks, Kenneth G Klobus, Kenneth H Williams, Kenneth M Gerlen, Kenneth M Gordon, Ko U Min, Kristen D Evans, Kristina Conroy, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Kristy A Zielny, Kyle D Covill, Kyle S Hobson, Larry K Austin, Latorie S Jones, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Linda M Hoover, Linda Thai, Lisa B Orr, Lisa Feela, Lisa M Bellows, LT John M Mastalski, LT Tamara J Henderson, Lucas B Leake, Luella J Rossi, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Maria Pkelly Doggett, MBA, Marian E Major, PhD, Marianela Aponte Cruz, Martha Sullivan Myrick, Mastalskij, Matther R Noonan, Matthew R Noonan, Maureen A Wentzel, Meena Bansal Gupta, PhD, Melissa B Libby, Melissa M Dauksis, Michael A Charles, Michael Curbag, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael R Goga, Michele L Obert, Michele M Falchek, Mihaly S Ligmond, Mike M Rashti, Monica E Caphart, Mra B Kamberem, Mra Mcculloughj, Myrick, Nikisha M Bolden, Omotunde O Osunsanmi, Patrick C Klotzbuecher, Paul L Figarole, Jr, Paula A Trost, Prabhu P Raju, Rabin N Ghoshal, Ramanda C Gregory, Ramon E Martinez, Rebecca K Olin, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Rina Bhikha, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Maffei, Robert P Neligan, Rochelle L Massey, Ronald A Stokes, Rose M Ashley, Sam Pepe, Sarah K Lemin, Scott E Norris, Sean D Duke, Seng Ching Hwang, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Shirley J Berryman, Shuang Tang, Simone E Pitts, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Stephen J Koniers, Stephen J Mottola, Steven A Rubin, Steven E Kane, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Tammy L Chavis, Tekalign Wondimu, Temar Q Williams, Thomas E Friel, Timothy T Kapsala, Tina S Roecklein, Todd J Maushart, Tonya O Corbin, Tricia S Martinez, Van Cliff, Victor J Gangi, Vlada Matusovsky, Wayne T Smith, Wei Wang, PhD, William C Brenneman, Xiao Wang, Yumi J Hiramine, Yvins Dezan, Yvonne C Mcknight, Yvonne C Wood, Zhong Li, PhD

Debra J Bennett's Documents

Publish Date Document Type Title
October, 2001 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2001-10-29
October, 2001 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2001-11-19
April, 2000 EIR Sanofi Chimie - EIR, 2000-05-23
November, 2001 EIR ICON Clinical Research - EIR, 2001-11-14
October, 2001 FDA 483 Ortho-McNeil Pharmaceutical Inc - Form 483, 2001-10-05
January, 2002 FDA 483 Fabbrica ItaLiana Sintetici S.p.A. - Form 483, 2002-01-11
March, 2000 FDA 483 Johnson & Johnson Consumer Inc. - Form 483, 2000-03-09
January, 2002 FDA 483 Response F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. - Form 483R, 2002-02-11
July, 2001 EIR Particle Size Technology Inc - EIR, 2001-07-19
November, 2001 FDA 483 AIRGAS THERAPEUTICS LLC - Form 483, 2001-11-02
February, 2001 EIR Charles River Laboratories Inc. - EIR, 2001-02-01
January, 2002 EIR F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. - EIR, 2002-01-11
September, 2002 FDA 483 Particle Size Technology Inc - Form 483, 2002-09-04
January, 2002 FDA 483 Profarmaco S.r.l. - Form 483, 2002-01-18
December, 2001 FDA 483 Omnicare Clinical Research - Form 483, 2001-12-07
October, 2001 EIR Merck Sharp & Dohme LLC - EIR, 2001-10-29
April, 2000 FDA 483 Aventis Pharma - Form 483, 2000-04-14
April, 2000 FDA 483 Response Sanofi Chimie - Form 483R, 2000-05-09
March, 2001 EIR Pharmaceutical Manufacturing Research Services, Inc. - EIR, 2001-03-28
March, 2000 EIR Johnson & Johnson Consumer Inc. - EIR, 2000-03-09
June, 2000 FDA 483 Pharmaceutical Manufacturing Research Services, Inc. - Form 483, 2000-06-29
June, 2000 FDA 483 Response Pharmaceutical Manufacturing Research Services, Inc. - Form 483R, 2000-07-07
December, 2001 EIR Omnicare Clinical Research - EIR, 2001-12-07
August, 2001 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2001-08-06
July, 2001 EIR Omnicare Pharmaceutics Inc. - EIR, 2001-07-09
January, 2001 FDA 483 Particle Size Technology Inc - Form 483, 2001-01-04
August, 2001 EIR Merck Sharp & Dohme LLC - EIR, 2001-08-06
April, 2000 FDA 483 PMC Isochem - Form 483, 2000-04-28
June, 2000 EIR Pharmaceutical Manufacturing Research Services, Inc. - EIR, 2000-06-29
November, 2001 EIR AIRGAS THERAPEUTICS LLC - EIR, 2001-12-03
April, 2000 EIR PMC Isochem - EIR, 2000-07-13
January, 2001 EIR Particle Size Technology Inc - EIR, 2001-01-04
December, 2000 FDA 483 Frontida BioPharm, LLC - Form 483, 2000-12-08
May, 2001 EIR Gador SA - EIR, 2001-06-12
July, 2001 FDA 483 Particle Size Technology Inc - Form 483, 2001-07-19
March, 2001 FDA 483 Pharmaceutical Manufacturing Research Services, Inc. - Form 483, 2001-03-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more